Drug Patent Expirations for the Week of December 31, 2023

TASIGNA (nilotinib hydrochloride) Novartis Patent: 7,169,791 Expiration: Jan 4, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…

The post Drug Patent Expirations for the Week of December 31, 2023 appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog